BioLineRx (BLRX) Tops Q1 EPS by 13c
BioLineRx (NASDAQ: BLRX) reported Q1 EPS of ($0.02), $0.13 better than the analyst estimate of ($0.15).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
BioLineRx (NASDAQ: BLRX) reported Q1 EPS of ($0.02), $0.13 better than the analyst estimate of ($0.15).
For earnings history and earnings-related data on BioLineRx (BLRX) click here.